Close Menu

NEW YORK (GenomeWeb) – Great Basin Scientific's reverse split of its common stock has taken effect, the firm announced today.

The 1-for-300 reverse split reduced the number of common stock shares from 199 million to 663,334 and was approved by the Financial Industry Regulatory Authority, following a special shareholder vote.

Also, Great Basin increased its number of authorized shares of common stock from 200 million to 1.5 billion shares.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

May
18
Sponsored by
Bio-Rad

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.